Our technology couples enzyme/receptor kinetics with branches of deep reinforcement learning overlaid onto first principles of physics and biology to automate networks/systems biology and pharmacology model simulations and empower drug discovery project teams to identify and validate the biological targets of diseases.
By leveraging artificial intelligence and publicly available databases, our proprietary algorithms create dynamical systems starting from digital reconstructions of human cells for predicting the effect of new drugs on cellular biology. From molecules to cellular homeostasis.
We believe in simplifying the drug discovery process. Instead of navigating through complex pathways and countless potential biological targets, you can now focus on your desired outcome. Whether it’s targeting specific cellular functions or achieving a particular therapeutic effect, Netabolics empowers you to set the goal, and the platform will handle the rest.
We help identify and validate the biological targets of disease, predicts the biological effects of new drugs and optimize their efficacy and toxicity profile, which translates in substantial time and cost savings.
Ready to revolutionize your drug discovery pipeline? Contact Netabolics today to explore how our AI-powered simulations can propel your projects forward. Specify your desired outcome, and let the future of drug discovery unfold with us.
Netabolics received funding from the European Regional Development Fund Pre-Seed Regione Lazio POR-FESR 2014-2020. The aim of the Pre-Seed grant (Prot. n. A0122-2020-34411 - 10/03/2020) is to support the development of the proprietary cloud platform of the company (as academic spin-off) and the consolidation of the business idea to make it ready for the market.
Netabolics and Netabolics logo are registered trademarks of Netabolics SRL. Copyright © 2020-2024 Netabolics. All rights reserved.